Picture of Vireo Growth logo

VREO Vireo Growth Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapValue Trap

Annual cashflow statement for Vireo Growth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-33.7-42.5-25.5-28-68.1
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items13.12718.911.251.5
Extraordinary Items
Unusual Items
Other Non-Cash Items
Changes in Working Capital-10-3.782.835.5416.6
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Cash from Operating Activities-30.5-18.1-0.966-10.23.71
Capital Expenditures-18-5.56-6.05-11.7-28.3
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items10.8-0.0552.583.5637.1
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-7.21-5.62-3.48-8.138.76
Financing Cash Flow Items0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities25.823.75.269418.4
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-12-0.0060.81575.630.9